IL6 and breast cancer: Considering that in the process of endothelium destruction there is an active release of proinflammatory cytokines, a promising area of research in the future may be the study of levels of interleukin-6, tumor necrosis factor-alpha in patients after breast cancer treatment and their comparison with the levels of intercellular adhesion molecules.